Literature DB >> 11841697

NK1.1+ cells and T-cell activation in euthymic and thymectomized C57Bl/6 mice during acute Trypanosoma cruzi infection.

F Cardillo1, F Q Cunha, W M S C Tamashiro, M Russo, S B Garcia, J Mengel.   

Abstract

Natural killer (NK) cells may provide the basis for resistance to Trypanosoma cruzi infection, because the depletion of NK1.1 cells causes high levels of parasitemia in young C57Bl/6 mice infected with T. cruzi. Indeed, NK1.1 cells have been implicated in the early production of large amounts of interferon (IFN)-gamma, an important cytokine in host resistance. The NK1.1 marker is also expressed on special subpopulations of T cells. Most NK1.1+ T cells are of thymic origin, and their constant generation may be prevented by thymectomy. This procedure, by itself, decreased parasitemia and increased resistance in young mice. However, the depletion of NK1.1+ cells by the chronic administration of a monoclonal antibody (MoAb) (PK-136) did not increase the parasitemia or mortality in thymectomized C57Bl/6 mice infected with T. cruzi (Tulahuen strain). To study the cross-talk between NK1.1+ cells and conventional T cells in this model, we examined the expression of activation/memory markers (CD45RB) on splenic CD4+ and CD8+ T cells from young euthymic or thymectomized mice with or without depletion of NK1.1+ cells and also in aged mice during acute infection. Resistance to infection correlated with the amount of CD4+ T cells that are already activated at the moment of infection, as judged by the number of splenic CD4+ T cells expressing CD45RB(-). In addition, the specific antibody response to T. cruzi antigens was precocious and an accumulation of immunoglobulin (Ig)M with little isotype switch occurred in euthymic mice depleted of NK1.1+ cells. The data presented here suggest that NK1.1+ cells have important regulatory functions in euthymic, but not in thymectomized mice infected with T. cruzi. These regulatory functions include a helper activity in the generation of effector or activated/memory T cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11841697     DOI: 10.1046/j.1365-3083.2002.01034.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  10 in total

1.  Interaction of natural killer cells with Trypanosoma cruzi-infected fibroblasts.

Authors:  T Lieke; C Steeg; S E B Graefe; B Fleischer; T Jacobs
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

2.  B cells modulate T cells so as to favour T helper type 1 and CD8+ T-cell responses in the acute phase of Trypanosoma cruzi infection.

Authors:  Fabiola Cardillo; Edilberto Postol; Jorge Nihei; Luiz S Aroeira; Auro Nomizo; José Mengel
Journal:  Immunology       Date:  2007-07-16       Impact factor: 7.397

Review 3.  Immunity and immune modulation in Trypanosoma cruzi infection.

Authors:  Fabíola Cardillo; Rosa Teixeira de Pinho; Paulo Renato Zuquim Antas; José Mengel
Journal:  Pathog Dis       Date:  2015-10-04       Impact factor: 3.166

4.  NK cells contribute to the control of Trypanosoma cruzi infection by killing free parasites by perforin-independent mechanisms.

Authors:  Thorsten Lieke; Sebastian E B Graefe; Ulricke Klauenberg; Bernhard Fleischer; Thomas Jacobs
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

5.  Administration of a nondepleting anti-CD25 monoclonal antibody reduces disease severity in mice infected with Trypanosoma cruzi.

Authors:  J Nihei; F Cardillo; W L C Dos Santos; L Pontes-de-Carvalho; J Mengel
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-05-21

6.  Role of IFN-alpha/beta and IL-12 in the activation of natural killer cells and interferon-gamma production during experimental infection with Trypanosoma cruzi.

Authors:  C Une; J Andersson; A Orn
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

7.  Nutritional Status Driving Infection by Trypanosoma cruzi: Lessons from Experimental Animals.

Authors:  Guilherme Malafaia; André Talvani
Journal:  J Trop Med       Date:  2011-04-14

8.  The Blockade of Interleukin-2 During the Acute Phase of Trypanosoma cruzi Infection Reveals Its Dominant Regulatory Role.

Authors:  Jorge Nihei; Fabiola Cardillo; Jose Mengel
Journal:  Front Cell Infect Microbiol       Date:  2021-11-17       Impact factor: 5.293

9.  C57BL/6 Mice Pretreated With Alpha-Tocopherol Show a Better Outcome of Trypanosoma cruzi Infection With Less Tissue Inflammation and Fibrosis.

Authors:  Amanda C O Silva; Maiara Bonfim; Jonathan L M Fontes; Washington L C Dos-Santos; José Mengel; Fabíola Cardillo
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 7.561

10.  The acute phase of Trypanosoma cruzi infection is attenuated in 5-lipoxygenase-deficient mice.

Authors:  Adriana M C Canavaci; Carlos A Sorgi; Vicente P Martins; Fabiana R Morais; Érika V G de Sousa; Bruno C Trindade; Fernando Q Cunha; Marcos A Rossi; David M Aronoff; Lúcia H Faccioli; Auro Nomizo
Journal:  Mediators Inflamm       Date:  2014-08-03       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.